Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

ROBERT ERIC HART

Allopathic & Osteopathic Physicians Family Medicine

NPI
1326044504
CMS profile
331721
Location
HICKORY, NC

General Payments · PY2018–2024

$5,266.57

  • Reported across 327 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$694.96

36 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $694.96 36

By paying entity

PY2024 · sorted by reported total

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $562.81 45
PY2019 $437.98 25
PY2020 $801.85 56
PY2021 $907.88 61
PY2022 $969.41 54
PY2023 $891.68 50
PY2024 $694.96 36

Payment records · PY2024 (36)

Sorted by paying entity, then date · as published by CMS

Program year 2024 201820192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
Actelion Pharmaceuticals US, Inc. $21.71 08/28/2024 Food and Beverage Undisputed 01/23/2026 1078897613 CMS
Astellas Pharma US Inc $17.61 07/08/2024 Food and Beverage Undisputed 01/23/2026 1139281324 CMS
AstraZeneca Pharmaceuticals LP $15.52 01/08/2024 Food and Beverage Undisputed 01/23/2026 1104716031 CMS
AstraZeneca Pharmaceuticals LP $19.59 01/30/2024 Food and Beverage Undisputed 01/23/2026 1105668079 CMS
AstraZeneca Pharmaceuticals LP $14.61 02/12/2024 Food and Beverage Undisputed 01/23/2026 1105613799 CMS
AstraZeneca Pharmaceuticals LP $16.84 02/13/2024 Food and Beverage Undisputed 01/23/2026 1104320482 CMS
AstraZeneca Pharmaceuticals LP $22.00 03/05/2024 Food and Beverage Undisputed 01/23/2026 1104752748 CMS
AstraZeneca Pharmaceuticals LP $21.45 03/20/2024 Food and Beverage Undisputed 01/23/2026 1104415105 CMS
AstraZeneca Pharmaceuticals LP $21.00 04/23/2024 Food and Beverage Undisputed 01/23/2026 1104610134 CMS
AstraZeneca Pharmaceuticals LP $24.92 05/14/2024 Food and Beverage Undisputed 01/23/2026 1104239379 CMS
AstraZeneca Pharmaceuticals LP $18.71 06/10/2024 Food and Beverage Undisputed 01/23/2026 1105264630 CMS
AstraZeneca Pharmaceuticals LP $22.52 06/18/2024 Food and Beverage Undisputed 01/23/2026 1104243101 CMS
AstraZeneca Pharmaceuticals LP $22.52 07/30/2024 Food and Beverage Undisputed 01/23/2026 1105881388 CMS
AstraZeneca Pharmaceuticals LP $15.30 09/03/2024 Food and Beverage Undisputed 01/23/2026 1104319842 CMS
AstraZeneca Pharmaceuticals LP $14.19 09/10/2024 Food and Beverage Undisputed 01/23/2026 1104524066 CMS
AstraZeneca Pharmaceuticals LP $19.11 10/16/2024 Food and Beverage Undisputed 01/23/2026 1105614651 CMS
Bayer Healthcare Pharmaceuticals Inc. $16.19 03/26/2024 Food and Beverage Undisputed 01/23/2026 1086251660 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $15.91 05/21/2024 Food and Beverage Undisputed 01/23/2026 1117963468 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $21.59 06/25/2024 Food and Beverage Undisputed 01/23/2026 1117963470 CMS
Dexcom, Inc. $24.94 04/01/2024 Food and Beverage Undisputed 01/23/2026 1153331443 CMS
GlaxoSmithKline, LLC. $20.40 08/08/2024 Food and Beverage Undisputed 01/23/2026 1116302156 CMS
GlaxoSmithKline, LLC. $24.79 09/24/2024 Food and Beverage Undisputed 01/23/2026 1116485795 CMS
IDORSIA PHARMACEUTICALS US INC $21.53 10/31/2024 Food and Beverage Undisputed 01/23/2026 1146793476 CMS
Inari Medical, Inc. $25.80 01/10/2024 Food and Beverage Undisputed 01/23/2026 1140104927 CMS
Lilly USA, LLC $17.61 01/16/2024 Food and Beverage Undisputed 01/23/2026 1135355580 CMS
Lilly USA, LLC $24.07 04/25/2024 Food and Beverage Undisputed 01/23/2026 1135368462 CMS
Lilly USA, LLC $16.63 12/20/2024 Food and Beverage Undisputed 01/23/2026 1135368460 CMS
Merck Sharp & Dohme LLC $21.59 02/06/2024 Food and Beverage Undisputed 01/23/2026 1141908814 CMS
Novo Nordisk Inc $17.50 01/23/2024 Food and Beverage Undisputed 01/23/2026 1097251418 CMS
Novo Nordisk Inc $14.62 03/04/2024 Food and Beverage Undisputed 01/23/2026 1097600932 CMS
Otsuka America Pharmaceutical, Inc. $24.88 03/27/2024 Food and Beverage Undisputed 01/23/2026 1118905975 CMS
Phathom Pharmaceuticals, Inc. $15.66 03/06/2024 Food and Beverage Undisputed 01/23/2026 1151070465 CMS
Phathom Pharmaceuticals, Inc. $17.49 05/07/2024 Food and Beverage Undisputed 01/23/2026 1151070467 CMS
Phathom Pharmaceuticals, Inc. $14.27 06/24/2024 Food and Beverage Undisputed 01/23/2026 1151070469 CMS
Phathom Pharmaceuticals, Inc. $13.47 08/19/2024 Food and Beverage Undisputed 01/23/2026 1151070471 CMS
Phathom Pharmaceuticals, Inc. $18.42 10/23/2024 Food and Beverage Undisputed 01/23/2026 1151070473 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.